ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IGC IGC Pharma Inc

0.501
-0.041 (-7.56%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
IGC Pharma Inc AMEX:IGC AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.041 -7.56% 0.501 0.633 0.49 0.628 1,707,510 00:58:55

Amended Statement of Changes in Beneficial Ownership (4/a)

15/09/2021 9:12pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

MUKUNDA RAM
2. Issuer Name and Ticker or Trading Symbol

India Globalization Capital, Inc. [ IGC ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
CEO
(Last)          (First)          (Middle)

10224 FALLS ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

9/15/2021
(Street)

POTOMAC, MD 20854
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

5/13/2021 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
COMMON STOCK 5/13/2021  A  1000000 (1)A$0.00 3174760 (2)D  
COMMON STOCK 5/13/2021  A  50000 (1)A$0.00 777417 I BY SPOUSE 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Represents restricted shares of common stock subject to vesting over three years.
(2) This Form 4 is being filed to reflect the correct ownership amount of the Reporting Person. All previous Section 16 filings of the Reporting Person since April 19, 2013 overstated the Reporting Person's ownership by 600,000 shares. Accordingly, the Reporting person owns 3,174,760 shares of Common Stock as opposed to the 3,774,760 shares previously reported on the Form 4.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
MUKUNDA RAM
10224 FALLS ROAD
POTOMAC, MD 20854
X
CEO

Signatures
/s/ Ram Mukunda9/15/2021
**Signature of Reporting PersonDate

1 Year IGC Pharma Chart

1 Year IGC Pharma Chart

1 Month IGC Pharma Chart

1 Month IGC Pharma Chart

Your Recent History

Delayed Upgrade Clock